Jian Zhang

6PUBLICATIONS
6CO-AUTHORS
Molecular targetsCancer cell biologyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 07, 2026
AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies.

|Jul 19, 2026
Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets.

|Jun 02, 2026
Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple-Negative Breast Cancer to PD-1 Blockade.

|May 08, 2026
Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases.

|Feb 10, 2026
Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Yifei Zhu, Teng Zhou, Yao Zheng

|Jul 03, 2025
Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Yifei Zhu, Teng Zhou, Yao Zheng

Pageof 1

Frequent Collaborators

1 joint publications

Shenglin Huang

1 joint publications

Xin Hu

1 joint publications

Xiaoxiang Guan

1 joint publications

Xichun Hu